• Home
  • The company
  • BioLogics portfolio
  • BioTec portfolio
  • Contact
  • News
    • Marketing & Sales
      • API Interferon alpha 2a
    • In-licensing / Out-licensing
  • Events

    API Interferon alpha 2a

    • 19 kDa Interferon alpha 2a
    • For the treatment of chronic Hepatitis B and chronic Hepatitis C in combination with Ribavirin®
    • Development according to all Interferon specific EMA-guidelines
      • CHMP/437/04
      • CHMP/BMWP/42832/2005
      • CHMP/BMWP/102046/2006
    • GMP material from Richter-Helm's own production plant in Germany
    Imprint | druckversionprint version | Sitemap
    Logout